NCT04785716View on ClinicalTrials.gov

Real-life Use of Niraparib in a Patient Access Program in Norway

CompletedOBSERVATIONAL
Enrollment

106

Participants

Timeline

Start Date

July 31, 2017

Primary Completion Date

August 3, 2020

Study Completion Date

August 3, 2020

Conditions
Ovarian CancerPeritoneal Cancer
Interventions
DRUG

Niraparib

Niraparib provided through the patient access program

Trial Locations (1)

0379

Oslo University Hospital (OUH), Oslo

All Listed Sponsors
collaborator

University Hospital of North Norway

OTHER

collaborator

St. Olavs Hospital

OTHER

collaborator

Haukeland University Hospital

OTHER

collaborator

Sorlandet Hospital HF

OTHER_GOV

lead

Kristina Lindemann

OTHER

NCT04785716 - Real-life Use of Niraparib in a Patient Access Program in Norway | Biotech Hunter | Biotech Hunter